The tumor suppressor genes BRCA1/2 are frequently mutated in familial breast and ovarian cancer, and around 10% of women diagnosed with these pathologies carry BRCA1/2 mutations [79]. This evidence concerns the gene BRCA1 and ovarian carcinoma.